Breaking News

You are here » Indian-Commodity  :  Equity & Shares  :  Central Bank of India surges despite reporting net loss of Rs 2,113.51 crore in Q4

18-May2018

Central Bank of India surges despite reporting net loss of Rs 2,113.51 crore in Q4

Central Bank of India is currently trading at Rs. 66.70, up by 0.80 points or 1.21% from its previous closing of Rs. 65.90 on the BSE.

The scrip opened at Rs. 66.50 and has touched a high and low of Rs. 67.25 and Rs. 62.00 respectively. So far 67538 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 125.00 on 22-May-2017 and a 52 week low of Rs. 62.00 on 18-May-2018.

Last one week high and low of the scrip stood at Rs. 70.55 and Rs. 62.00 respectively. The current market cap of the company is Rs. 17253.65 crore.

The promoters holding in the Bank stood at 86.40%, while Institutions and Non-Institutions held 10.57% and 3.03% respectively.

The Bank has reported a net loss of Rs 2,113.51 crore for the quarter ended March 31, 2018 as compared net loss of Rs 591.77 crore for the same quarter in the previous year. Total income of the Bank decreased by 11.51% at Rs 6,301.50 crore for quarter under review as compared to Rs 7,121.05 crore for the quarter ended March 31, 2017.

For the year ended March 31, 2018, the Bank has posted a net loss at Rs 5,104.91 crore as compared to net loss of Rs 2,439.10 crore for the previous year. Total income of Bank decreased by 3.19% at Rs 26,657.86 crore for year under review as compared to Rs 27,537.05 crore for the year ended March 31, 2017.


Related News

View all news

IndusInd Bank surges on reporting 5% rise in Q2 net profit

IndusInd Bank is currently trading at Rs. 1663.60, up by 36.75 points or 2.26% from its previous closing of Rs. 1626.85 on the BSE.The scrip opened at Rs. 1638.00 and has touched a high and low of Rs.......

Lupin rises with arm partnering with ASHA, NPWH

Lupin is currently trading at Rs. 897.00, up by 16.55 points or 1.88% from its previous closing of Rs. 880.45 on the BSE.The scrip opened at Rs. 889.80 and has touched a high and low of Rs. 910.00 and......

Alembic Pharma surges with receiving USFDA's tentative approval for Alogliptin Tablet

Alembic Pharmaceuticals is currently trading at Rs. 602.35, up by 6.50 points or 1.09% from its previous closing of Rs. 595.85 on the BSE.The scrip opened at Rs. 596.65 and has touched a high and low of......

Top News

View all news

Shalimar Paints lays down foundation of Nashik manufacturing plant

Shalimar Paints has laid down the foundation of a manufacturing unit to be rebuilt in Nashik, in the state of Maharashtra. The company set to commence operations by April 2019 with a planned production......

Delta Corp reports 11% rise in Q2 consolidated net profit

Delta Corp has reported results for second quarter ended September 30, 2018.The company has reported over 2-fold jump in its net profit at Rs 63.51 crore for the quarter under review as compared to Rs......

PNB plans to sell non-core assets worth Rs 8,600 crore during FY19

Punjab National Bank (PNB) has recognized various assets, including its housing finance arm, for sale and hopes to realise Rs 8,600 crore from these non-core assets during the current fiscal. Meanwhile,......